Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
glimepiride (amaryl) (1 trial)
saxagliptin (onglyza) (1 trial)
aclarubicin (1 trial)
azacitidine (vidaza) (1 trial)
cisplatin (platinol) (1 trial)
decitabine (dacogen) (1 trial)
docetaxel (taxotere) (1 trial)
gimeracil (1 trial)
oteracil (1 trial)
s-1 (1 trial)
tegafur (1 trial)
venetoclax (venclexta) (1 trial)
almonertinib (1 trial)
bevacizumab (avastin) (1 trial)
ensartinib (1 trial)
lapatinib (tykerb) (1 trial)
Raltitrexed (1 trial)
hcd19.il15.car-inkt (1 trial)
tianqi pingchan (1 trial)
Carcinoma (Phase 3)
Carcinoma, Squamous Cell (Phase 3)
Diabetes Mellitus, Type 2 (Phase 4)
Esophageal Neoplasms (Phase 3)
Esophageal Squamous Cell Carcinoma (Phase 3)
Trials (10 total)
Trial APIs (19 total)